LabCorp
LH
#925
Rank
NZ$45.43 B
Marketcap
NZ$560.22
Share price
-1.09%
Change (1 day)
20.66%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$19.40

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$19.20. In 2025 the company made an earnings per share (EPS) of NZ$17.80 an increase over its 2024 EPS that were of NZ$15.02.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$19.409.03%
2025NZ$17.8018.45%
2024NZ$15.0289.15%
2023NZ$7.94-66.26%
2022NZ$23.54-43.33%
2021NZ$41.5454.11%
2020NZ$26.9689.43%
2019NZ$14.23-3.33%
2018NZ$14.72-29.7%
2017NZ$20.9475.74%
2016NZ$11.9263.19%
2015NZ$7.30-28.4%
2014NZ$10.20-6.13%
2013NZ$10.865.2%
2012NZ$10.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$23.15 20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.50-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.30-106.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.29-82.85%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.35-101.85%๐Ÿ‡บ๐Ÿ‡ธ USA